Summary Bioneer Corp (Bioneer) is a molecular diagnostic company that carries out the development and production of molecular research and molecular diagnostic products and instruments. The molecular research products of the company includes DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and reagents, RNAi, enzymes, protein expression and purification, ladders and markers, yeast genome-wide library, drug target and toxicity identification services, buffer and sequencing reagent and plastic consumables. It also offers equipment, such as, protein synthesis and nucleic acid extraction system, PCR systems, Real-Time PCR systems, sample preparation systems, centrifuge and vortex mixer and electrophoresis system. Its molecular diagnostic product includes human diagnostic kits, veterinary diagnostic kits, MDx instruments and diagnostic reagent technologies. The company operates the world over through its subsidiaries in the US, Australia and China. Bioneer is headquartered in Daejeong, South Korea. Bioneer Corp (064550) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers... Research Beam Model: Research Beam Product ID: 1915891 250 USD New
Bioneer Corp (064550) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Bioneer Corp (064550) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : July   2017
  • Pages : 22
  • Publisher : GlobalData
 
 
 
Summary

Bioneer Corp (Bioneer) is a molecular diagnostic company that carries out the development and production of molecular research and molecular diagnostic products and instruments. The molecular research products of the company includes DNA/RNA amplification pre mixes, DNA/RNA preparation system, oligo synthesis and reagents, RNAi, enzymes, protein expression and purification, ladders and markers, yeast genome-wide library, drug target and toxicity identification services, buffer and sequencing reagent and plastic consumables. It also offers equipment, such as, protein synthesis and nucleic acid extraction system, PCR systems, Real-Time PCR systems, sample preparation systems, centrifuge and vortex mixer and electrophoresis system. Its molecular diagnostic product includes human diagnostic kits, veterinary diagnostic kits, MDx instruments and diagnostic reagent technologies. The company operates the world over through its subsidiaries in the US, Australia and China. Bioneer is headquartered in Daejeong, South Korea.

Bioneer Corp (064550) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioneer Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bioneer Corp, Medical Devices Deals, 2011 to YTD 2017 9
Bioneer Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bioneer Corp, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
Sanofi Enters Into Research Agreement With Bioneer 11
Licensing Agreements 12
Yuhan Enters into Licensing Agreement with Bioneer 12
Equity Offering 13
Bioneer Raises USD15.6 Million in Rights Offering of Shares 13
Bioneer to Raise USD4.3 Million in Private Placement of Shares 14
Bioneer Raises USD8.5 Million in Private Placement of Shares 15
Bioneer Raises USD1.9 Million in Private Placement of Shares 16
Debt Offering 17
Bioneer Completes Private Placement Of Fourth Bonds Due 2016 For US$3 Million 17
Bioneer Completes Private Placement Of Third Bonds Due 2015 For US$3 Million 18
Bioneer Corp - Key Competitors 19
Key Employees 20
Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22
List of Tables
Bioneer Corp, Pharmaceuticals & Healthcare, Key Facts, 2015 1
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioneer Corp, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioneer Corp, Deals By Therapy Area, 2011 to YTD 2017 8
Bioneer Corp, Medical Devices Deals, 2011 to YTD 2017 9
Bioneer Corp, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Bioneer Enters Into Research Agreement with La Jolla Institute for Allergy and Immunology 11
Sanofi Enters Into Research Agreement With Bioneer 11
Yuhan Enters into Licensing Agreement with Bioneer 12
Bioneer Raises USD15.6 Million in Rights Offering of Shares 13
Bioneer to Raise USD4.3 Million in Private Placement of Shares 14
Bioneer Raises USD8.5 Million in Private Placement of Shares 15
Bioneer Raises USD1.9 Million in Private Placement of Shares 16
Bioneer Completes Private Placement Of Fourth Bonds Due 2016 For US$3 Million 17
Bioneer Completes Private Placement Of Third Bonds Due 2015 For US$3 Million 18
Bioneer Corp, Key Competitors 19
Bioneer Corp, Key Employees 20
Bioneer Corp, Subsidiaries 21List of Figures
Bioneer Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Bioneer Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Bioneer Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Bioneer Corp, Medical Devices Deals, 2011 to YTD 2017 9
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter